Health Condition 1: L63- Alopecia areata
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male and Female participants, whose age is more than 18 years; 2. Participants who are willing to give written, signed and dated informed consent to participate in the study. 3. Participants who are clinically diagnosed for diffuse hair, Hair loss, minimum hair growth
Exclusion criteria
Exclusion criteria: 1. Pregnant or breastfeeding or planning to become pregnant during the study period. 2. Known case of Hypersensitivity to Investigational drug content. 3. Patient using any other treatment for this indication at the same time 4. Received any other investigational medicinal therapy within 30 days and topical therapy within 7 days prior to screening 5. Patient suffering from any active general illness or have History of any general illness 6. Patient on chemotherapy/ Radiotherapy/Tuberculosis 7. K/C/O of Diabetes, Immuno compromised condition Like HIV I and II, HbsAg 8. Any condition or disease which is considered unfit for study and which may interfere with study therapy as decided by clinical investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hair Growth /Regrowth Increase in hair density (by Trichoscope) Improvement in Hair Texture Preventing Hair Loss â?¢ Dandruff, Itching, Dryness, Stiffness of Hair, Perspiration and Burning Sensation In ScalpTimepoint: 0 day, 40th day, 80th day and 120th day | — |
Secondary
| Measure | Time frame |
|---|---|
| Subjective: Hair Growth, Dandruff, Itching, Dryness, Stiffness of Hair, Perspiration and Burning Sensation In Scalp Objective: Serum Ferritin levelsTimepoint: Subjective: 1, 40, 80 and 120 days Objective: Serum Ferritin, CBC - 0 and 120 days | — |
Countries
India
Contacts
KAHERs Shri B M Kankanawadi Ayurveda Mahavidyalaya Belagavi